BCG VACCINE - AN INNOVATION FOR DIABETES TREATMENT IN PAKISTAN?
AbstractPakistan is a third world country with very small health budget and a diabetes prevalence of about 6.9% among adults, accounting for over 86,000 deaths. If phase 2 trials testing the ability of BCG to reverse type 1 Diabetes become successful in remission of insulin from pancreas this would be very useful to treat diabetes in Pakistan as BCG is readily available, less expensive, has less storage problems, less side effects and doesn't require skilful person to administer. Keywords: Diabetes; BCG; Pakistan
International Diabetes Federation [Internet]. Diabetes in Pakistan - 2015.Available from: http://www.idf.org/membership/mena/pakistan. 2. Kathleen M. Gillespie. Type 1 diabetes: pathogenesis and prevention. CMAJ. 2006 Jul 18; 175(2): 165–70. 3. Denise L. Faustman,, Limei Wang, Yoshiaki Okubo, Douglas Burger, Liqin Ban, Guotong Man, Hui Zheng, David Schoenfeld, Richard Pompei,Joseph
J Ayub Med Coll Abbottabad 2017;29(1)
Avruch, and David M. Nathan et al. Proof-of-Concept, Randomized, Controlled Clinical Trial of BacillusCalmette-Guerin for Treatment of Long-Term Type 1 Diabetes. PLoS One. 2012; 7(8): e41756. 4. Shinichiro Ryu, Shohta Kodama, Kazuko Ryu, David A. Schoenfeld, and Denise L. Faustman. Reversal of established autoimmune diabetes by restoration of endogenous β cell function. J Clin Invest. 2001 Jul 1; 108(1): 63–72. 5. Marceline Huppmann, Andrea Baumgarten, DIPSOCSC, Anette-G. Ziegler, MD and Ezio Bonifacio,
PHD et al. Neonatal Bacille Calmette-Guerin Vaccination and Type 1 Diabetes. Diabetes Care 2005 May; 28(5): 1204-1206. 6. Allen HF1, Klingensmith GJ, Jensen P, Simoes E, Hayward A, Chase HP et al. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study. Diabetes Care. 1999 Oct;22(10):1703-7